Found in 1989, Synmax is a leading technology company focused on developing cost-effective intermediates for the pharmaceutical market as well as specialty chemicals for the electronics industry. Relying on our synthesis and bioconversion platform, Synmax offers a broad range of products and services. While maintaining our production of 7-ADCA, an intermediate for the cephalosporin antibiotics, we have developed a new series of intermediates for cardiovascular drugs using bioprocess. Relying o...